Glooko is a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum. We’re uniquely positioned to be the enterprise partner of choice for healthcare providers seeking to reduce glycemic risk, improve safety, and support overburdened clinical teams with coordinated expertise across both outpatient and inpatient care settings. Our connected care solutions portfolio includes the outpatient Glooko diabetes management platform, Glooko Mobile App for people with diabetes, inpatient EndoTool Glucose Management System, and the Glooko XT remote patient monitoring platform in France.
Looking for a particular Glooko employee's phone or email?
The Glooko annual revenue was $15.8 million in 2026.
Yogen Dalal is the Founder, Investor of Glooko.
198 people are employed at Glooko.
Glooko is based in Palo Alto, California.
The NAICS codes for Glooko are [519, 518, 51919, 51, 519190, 5191].
The SIC codes for Glooko are [73, 737].